国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2009年
11期
1052-1054
,共3页
孟令国%李和楼%赵建香%王克强%杨洪云%葛建华
孟令國%李和樓%趙建香%王剋彊%楊洪雲%葛建華
맹령국%리화루%조건향%왕극강%양홍운%갈건화
肝炎病毒,乙型%DNA%临床实验室技术
肝炎病毒,乙型%DNA%臨床實驗室技術
간염병독,을형%DNA%림상실험실기술
Hepatitis B virus%DNA%Clinical laboratory techniques
目的 分析HBV DNA与PreS1以及ALT在乙型肝炎患者血清中的检测情况,分析其相互关系,评价其联合检测的价值.方法 采用荧光定量PCR法检测HBV DNA,同时用ELISA方法检测PreS1蛋白、动力学方法检测ALT,并分析其相互关系.结果 HBeAg阳性组中HBV DNA、PreS1检出率分别为97.1%、94.3%(x~2=0.17,P>0.05).HBsAg+、抗HBe+和抗HBc+组中HBV DNA、PreS1的检出率分别为47.4%、73.7%,表明部分HBeAg阴性、抗HBe+患者仍有病毒复制.HBsAg+、抗HBc+组中HBV DNA、PreS1的检出率分别为65.8%、89.5%,而ALT在这3组中的异常率差异无统计学意义(x~2分别为2.18、1.93、0.03,均P>0.05),说明血清ALT虽对肝细胞损害极为敏感但缺乏特异性.ALT异常组中HBV DNA和PreS1检出率分别为78.6%、86.3%,两者相关性较高(x~2=2.64,P>0.05),ALT正常组中HBV DNA和PreS1检出率差异有统计学意义(x~2=9.68,P<0.01).PreS1与HBV DNA检出率不一致,可能是PreS1和HBV DNA检测所表达的意义并不完全一致.结论 HBV DNA、PreS1以及ALT在乙型肝炎患者血清中所表达的意义各有侧重,在实际工作中应联合检测,互相补充,这样对乙型肝炎患者的诊断与治疗会有更高的临床价值.
目的 分析HBV DNA與PreS1以及ALT在乙型肝炎患者血清中的檢測情況,分析其相互關繫,評價其聯閤檢測的價值.方法 採用熒光定量PCR法檢測HBV DNA,同時用ELISA方法檢測PreS1蛋白、動力學方法檢測ALT,併分析其相互關繫.結果 HBeAg暘性組中HBV DNA、PreS1檢齣率分彆為97.1%、94.3%(x~2=0.17,P>0.05).HBsAg+、抗HBe+和抗HBc+組中HBV DNA、PreS1的檢齣率分彆為47.4%、73.7%,錶明部分HBeAg陰性、抗HBe+患者仍有病毒複製.HBsAg+、抗HBc+組中HBV DNA、PreS1的檢齣率分彆為65.8%、89.5%,而ALT在這3組中的異常率差異無統計學意義(x~2分彆為2.18、1.93、0.03,均P>0.05),說明血清ALT雖對肝細胞損害極為敏感但缺乏特異性.ALT異常組中HBV DNA和PreS1檢齣率分彆為78.6%、86.3%,兩者相關性較高(x~2=2.64,P>0.05),ALT正常組中HBV DNA和PreS1檢齣率差異有統計學意義(x~2=9.68,P<0.01).PreS1與HBV DNA檢齣率不一緻,可能是PreS1和HBV DNA檢測所錶達的意義併不完全一緻.結論 HBV DNA、PreS1以及ALT在乙型肝炎患者血清中所錶達的意義各有側重,在實際工作中應聯閤檢測,互相補充,這樣對乙型肝炎患者的診斷與治療會有更高的臨床價值.
목적 분석HBV DNA여PreS1이급ALT재을형간염환자혈청중적검측정황,분석기상호관계,평개기연합검측적개치.방법 채용형광정량PCR법검측HBV DNA,동시용ELISA방법검측PreS1단백、동역학방법검측ALT,병분석기상호관계.결과 HBeAg양성조중HBV DNA、PreS1검출솔분별위97.1%、94.3%(x~2=0.17,P>0.05).HBsAg+、항HBe+화항HBc+조중HBV DNA、PreS1적검출솔분별위47.4%、73.7%,표명부분HBeAg음성、항HBe+환자잉유병독복제.HBsAg+、항HBc+조중HBV DNA、PreS1적검출솔분별위65.8%、89.5%,이ALT재저3조중적이상솔차이무통계학의의(x~2분별위2.18、1.93、0.03,균P>0.05),설명혈청ALT수대간세포손해겁위민감단결핍특이성.ALT이상조중HBV DNA화PreS1검출솔분별위78.6%、86.3%,량자상관성교고(x~2=2.64,P>0.05),ALT정상조중HBV DNA화PreS1검출솔차이유통계학의의(x~2=9.68,P<0.01).PreS1여HBV DNA검출솔불일치,가능시PreS1화HBV DNA검측소표체적의의병불완전일치.결론 HBV DNA、PreS1이급ALT재을형간염환자혈청중소표체적의의각유측중,재실제공작중응연합검측,호상보충,저양대을형간염환자적진단여치료회유경고적림상개치.
Objective To analyze the association of HBV DNA,PreS1 with ALT,and evaluate the clinical value of combined detection.Methods Fluorescence quantitative PCR was applied to detecring HBV DNA,enzyme linked immunosorbent assay(ELISA)was adopted to measure PreS1 protein,and kinetic method was employed to measure serum level of alanine aminotransferase(ALT).The teat results were compared and analyzed.Results The detection rates of HBV DNA and PreS1 were respectively 97.1%and 94.3%in HBeAg positive group,with a highly positive correlation(X~2=0.17,P>0.05),while in the HBsAg+,anti-HBe+and anti-HBc+group,the detection rates were respectively 47.4%and 73.7%,indicating that the viral replication still occurred in some patients with anti-HBe positive,HBeAg negative.The detection rates of HBV DNA and PreS1 were respectively 65.8%and 89.5%in HBsAg+,anti-HBc+group.However,the detection rates of ALT in these three groups were no significant difference(X~2 was 2.18,1.93 and 0.03 respectively,P>0.05).It was illustrated that the ALT was sensitive to hepatocyte damage but not specific.The detection rates of HBV DNA and Presl were respectively 78.6%and 86.3%in ALT abnormal group,with high positive correlation(X~2=2.64,P>0.05).While in the group of normal ALT group,HBV DNA and Pres1 detection rates were quite different,showing their different clinical significance(X~2=9.68,P<0.01).Conclusion The clinical value of HBV DNA,Pres1 and ALT in HBV patients is different,so combined detection shoule be performed so as to improve diagnosis and treatment of hepatitis B.